Market Size of Global Hydrophobic Interaction Chromatography Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.60 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Hydrophobic Interaction Chromatography Market Analysis
The hydrophobic interaction chromatography market is expected to witness a CAGR of 7.6% during the forecast period.
The impact of the COVID-19 pandemic was significant on the studied market owing to the increased demand for vaccine production and manufacturing by various pharmaceutical and biotech companies worldwide, deploying chromatography, which ultimately impacted the market. For instance, a research article titled "Mechanistic Modeling for a Hydrophobic-Interaction Chromatography Process: Use in Vaccine Antigen Purification" was published in Bioprocessing International in September 2022 that proposed a model for the Industrial HIC process. Also, in December 2020, the Pfizer-BioNTech COVID-19 vaccine Comirnaty, one of the first vaccines to be made available under the emergency use authorization (EUA) for those 16 years of age and older was approved by the United States Food and Drug Administration. With the rising demand for vaccines for infectious and chronic diseases and increasing research studies, the demand for hydrophobic interaction chromatography is expected to grow.
In addition, the growing demand for monoclonal antibodies and increasing research and development investment in oncology and analytic techniques are actively affecting the growth of the studied market.
According to the Globocan 2020 fact sheet, an estimated 19,292,789 new cancer cases were diagnosed worldwide, with nearly 9,958,133 deaths due to cancers, globally. Additionally, according to estimates from the International Agency for Research on Cancer (IARC), the global burden of cancers is expected to grow to 27.5 million new cancer cases worldwide by 2040. The increasing incidence of cancer cases is expected to drive the need for monoclonal antibodies and expedite research and development in oncology sector to develop a noval treatment, which uses hydrophobic interaction chromatography for the purification process and is ultimately projected to boost the market growth.
The growth is attributed to increasing demand for monoclonal antibodies in the treatment of many fatal diseases coupled with increasing launches and approvals by the key market players. For instance, in February 2022, a new monoclonal antibody, bebtelovimab received the United States Food and Drug Administration emergency use authorization (EUA) for the treatment of COVID-19 while maintaining activity against the omicron variant. Such developments are anticipated to boost the utility of chromatography which is projected to boost the market segment.
Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. However, the lack of skilled professionals and the availability of other chromatography techniques are likely to impede the market growth.
